PAFAH2
MOLECULAR TARGETplatelet activating factor acetylhydrolase 2
PAFAH2 (platelet activating factor acetylhydrolase 2) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PAFAH2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Quinestrol | 1.10 | 2 |
| 2 | Diiodotyrosine | 0.69 | 1 |
| 3 | Ethidium | 0.69 | 1 |
| 4 | Hexachlorophene | 0.69 | 1 |
| 5 | Oxytetracycline | 0.69 | 1 |
About PAFAH2 as a Drug Target
PAFAH2 (platelet activating factor acetylhydrolase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented PAFAH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PAFAH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.